换一批
换一批Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
作者：
Lucas,Moreno [1]
;
Giuseppe,Barone [2]
;
Steven G,DuBois [3]
;
Jan,Molenaar [4]
;
Matthias,Fischer [5]
;
Johannes,Schulte [6]
;
Angelika,Eggert [7]
;
Gudrun,Schleiermacher [8]
;
Frank,Speleman [9]
;
Louis,Chesler [10]
;
Birgit,Geoerger [11]
;
Michael D,Hogarty [12]
;
Meredith S,Irwin [13]
;
Nick,Bird [14]
;
Guy B,Blanchard [15]
;
Sean,Buckland [16]
;
Hubert,Caron [17]
;
Susan,Davis [18]
;
Bram,De Wilde [9]
;
Hedwig E,Deubzer [19]
;
Emmy,Dolman [20]
;
Martin,Eilers [21]
;
Rani E,George [3]
;
Sally,George [10]
;
Štěrba,Jaroslav [22]
;
John M,Maris [12]
;
Lynley,Marshall [10]
;
Melinda,Merchant [23]
;
Peter,Mortimer [23]
;
Cormac,Owens [24]
;
Anna,Philpott [25]
;
Evon,Poon [26]
;
Jerry W,Shay [27]
;
Roberto,Tonelli [28]
;
Dominique,Valteau-Couanet [11]
;
Gilles,Vassal [29]
;
Julie R,Park [30]
;
Andrew D J,Pearson [10]
作者单位：
Paediatric Haematology & Oncology Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: lucas.moreno@vhebron.net.
[1]
Department of Paediatric Oncology, Great Ormond Street Hospital for Children, London, UK.
[2]
Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA, USA.
[3]
Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
[4]
Experimental Pediatric Oncology, University Children's Hospital, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
[5]
Department of Pediatric Oncology & Hematology, Charité University Hospital, Berlin, Germany.
[6]
Department of Pediatric Oncology & Hematology, Charité University Hospital, Berlin, Germany; German Cancer Consortium (DKTK Berlin), Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany.
[7]
SIREDO, Department of Paediatric, Adolescents and Young Adults Oncology and INSERM U830, Institut Curie, Paris, France.
[8]
Center for Medical Genetics Ghent (CMGG), Department of Biomolecular Medicine, Cancer Research Institute Ghent (CRIG), Belgium.
[9]
Paediatric Drug Development, Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
[10]
Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, University Paris-Saclay & Inserm U1015, Villejuif, France.
[11]
Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, USA.
[12]
Department of Paediatrics, Medical Biophysics and Laboratory Medicine & Pathobiology, The Hospital for Sick Kids, Toronto, Canada.
[13]
Solving Kids' Cancer, UK and National Cancer Research Institute Children's Cancer & Leukaemia Clinical Studies Group, UK.
[14]
Neuroblastoma UK & Department of Physiology, Development & Neuroscience, University of Cambridge, UK.
[15]
Pfizer Ltd, Surrey, UK.
[16]
Hoffmann-La Roche Ltd, Basel, Switzerland.
[17]
Cyclacel Limited, Dundee, UK.
[18]
Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, Germany.
[19]
Department of Translational Research, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
[20]
Department of Biochemistry and Molecular Biology, University of Wuerzburg, Germany.
[21]
Pediatric Oncology Department, University Hospital Brno, School of Medicine Masaryk University Brno, Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, ICRC Brno, St Anna University Hospital Brno, Czech Republic.
[22]
Astrazeneca, Early Clinical Projects, Oncology Translation Medicines Unit, Innovative Medicines Unit, Cambridge, UK.
[23]
Department of Paediatric Haemaology/Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
[24]
Department of Oncology, University of Cambridge, UK.
[25]
Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.
[26]
Department of Cell Biology, UT Southwestern Medical Center, Dallas, TX, USA.
[27]
Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
[28]
Department of Clinical Research, Gustave Roussy, Paris-Sud University, Paris, France.
[29]
Department of Pediatrics, University of Washington School of Medicine and Center for Clinical and Translational Research, Seattle Children's Hospital, USA.
[30]
主题词
抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);儿童(Child);会议(主题)(Congresses as Topic);药物发现(Drug Discovery);欧洲(Europe);人类(Humans);医学肿瘤学(Medical Oncology);分子靶向治疗(Molecular Targeted Therapy);神经母细胞瘤(Neuroblastoma);儿科学(Pediatrics);蛋白激酶抑制剂(Protein Kinase Inhibitors);治疗, 临床研究性(Therapies, Investigational)
DOI
10.1016/j.ejca.2020.05.010
PMID
32653773
发布时间
2024-03-06
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
